Proportion of medical insurance reimbursement for stem cell transplantation

Legal analysis: the reimbursement ratio is certain. The medical expenses incurred by the insured in the process of hematopoietic stem cell transplantation that meet the scope of payment of basic medical insurance can be paid by the basic medical insurance fund as long as they are included in the scope of reimbursement of basic medical insurance.

Legal basis: People's Republic of China (PRC) Social Insurance Law.

Twenty-eighth medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency treatment and rescue shall be paid by the basic medical insurance fund in accordance with state regulations.

Twenty-ninth medical expenses of the insured shall be paid by the basic medical insurance fund, and shall be directly settled by the social insurance agency, medical institutions and pharmaceutical business units.

The administrative department of social insurance and the administrative department of health shall establish a settlement system for medical expenses in different places to facilitate the insured to enjoy the basic medical insurance benefits.